|

PEP-CMV Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Nationwide Children's Hospital1

Indications

  • Recurrent Medulloblastoma1
  • Diffuse Intrinsic Pontine Glioma1
  • High Grade Glioma1
  • Cancer1

Aurora, Colorado1 trial

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Children's Hospital Colorado

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.